A Strategic Innovation Program in
Medical Technology
• A strategic research and innovation program financed
by VINNOVA, Sweden’s innovation agency
• MedTech4Health addresses one of the largest global
social challenges and stimulates the international
competitiveness of industry in Sweden and research
in a globally growing market
• MedTech4Health - the role of technology in today's
and tomorrow's health
Vision
Medicinteknisk industri verksam i Sverige är internationellt
ledande med hjälp av ett världsunikt forsknings-och
innovationssystem, där forskning, vård, och industri
samverkar och bidrar till bättre hälsa!
A Strategic Innovation Program in
Medical Technology
Short facts
• 3 year project with option to
prolong for 3+3 years
• 10 M€ for the first 3 years
• Starting in 2016
Participating parties
•
•
•
•
•
Research institutes
11 counties
7 University hospitals
10 Universitys
64 Medtech companies
A Strategic Innovation Program in
Medical Technology
Short-term goals
Long term goals
• Increase patient perspective for
innovation in health care
• Improve exchange between cross
competencies
• Health and social care directly
involved in innovation processes
• A patient-centered and efficient
healthcare system in terms of
health outcomes per cost
• Continued national and
international success of MedTech
companies in Sweden
• Sweden internationally
recognized for excellence in
medical technology innovation,
research and education
• National coordination
w ww.ctmh.se
[email protected]
Medtech4Health – Key Initiativs
KI One: Project
calls
• Project calls with
patient focus.
• Mobility boost
checks.
KI Two: Shortening
”Valley of Death”
KI Three: Network,
Attitudes and
collaboration
• Bridging the gap by
verification in the
clinical setting and
pilot studies
• Cross competencies
educations
(technology,
medicine, clinic)
• International
collaborations
• ”Health care
innovator of the year
award”
• Advocacy, education
and information for
decision-makers
Parties
NORRLANDSREGIONEN
Luleå tekniska universitet
Umeå universitetet
Norrbottens läns landsting
Västerbottens läns landsting
Nodrepresentant: Centrum för medicinskt t eknik
och fysik (CMTF)
UPPSALA
Uppsala universitet
Landstinget i Uppsala län
Nodrepresentant: Centrum för bildanalys (CBA)
SP Sveriges Tekniska Forskningsinstitut
Svensk förening för medicinsk t eknik och fysisk (MTF)
Swedish Medtech, branschorganisationen för
medicinteknikföretag
STOCKHOLM
Karolinska Institutet
Kungliga tekniska högskolan
Stockholms läns landsting
Nodrepresentant: Centrum för t eknik i medicin och
hälsa (CTMH)
VÄSTRA GÖTALANDSREGIONEN VGR
ÖSTRA MELLANSVERIGE
Chalmers Tekniska högskola
Göteborgs Universitet
Högskolan i Borås
Västra Götalandsregionen, VGR
Nodrepresentant: MedTech West
Linköpings universitet
Mälardalens högskola
Örebro universitet
Landstinget i Västmanland
Södermanlands läns landsting
Örebro läns landsting
Östergötlands läns landsting
Berörda kommuner i resp. län
Nodrepresentant: Novamedtech
SKÅNE
Lunds Universitet
Region Skåne
Nodrepresentant: Skånskt centrum för medicint eknik
(under bildande)
)
Industry: 64
Patient organizations: 5
Research institute: 3
Univ Hospital: 7
Academy: 10
Others: 15
Total: 108
Activities
1. Innovation calls
2. ”Innovator in residence” – Pilots with support from counties/hospitals
3. Mobility boost for clinical innovation
4. Education and Development of Cross-competences
5. Verification of innovations in a clinical environment
6. Translational Hubs
7. Support for certification and approval process
8. Accelerating international collaboration
9. ”Health care innovator of the year award”
10. Increased awareness and knowledge through collaboration
1. Innovation calls
Description:
• Supporting for applications for R&I projects in biomedical engineering.
• Selected to make the greatest contribution and that also have commercial potential.
• Patient and clinical relevance will be a primary evaluation criterion.
• Projects should be multi-professional and run in close collaboration of the health-care system,
industry, the academic community and, where appropriate, patients (users) and/or patient
organizations.
Number of projects: 15-20 calls / year
Budget: 15-20 MSEK / year in total.
Targeted groups: Partnering teams from the healthcare sector, industry, institutes, the academic
community, and, where appropriate, users and/or
patient organizations.
2. Innovator in residence
Description:
• A call for clinical staff engaging in critical moments for medtech innovations, such as
participating in expert groups for procurement or assessment of new medical technology.
• This activity is to support health care in its own process of development and change
• Clinicians are expected to analyze the clinical needs where innovative processes and/or
products are required.
Number of projects: 5 -8 projects / year. Up to
1 MSEK / application.
Budget: 3-5 MSEK / year
Targeted groups: Nurses, doctors, health-care
staff.
3. Mobility boost
Description:
• Mobility Boost is a check granted to SMEs, but for financing costs of others, namely their partners
in the project, being clinicians, researchers or patient organizations.
• The needs may vary in summarizing available scientific evidence for the novel method or product,
in advice on how to organize a clinical study, in formalizing a method, for example.
• 200,000 SEK to be paid to the collaborating clinical or academic parties. The SIP nodes
will aid in connecting the right parties.
Number of projects: 10-15 / year. Up to 200k
SEK / project.
Budget: 3 MSEK / year
Targeted groups: SME
4. Education and Development of
Cross-competences
Description:
• Support new and further develop existing initiatives creating opportunities for Education and
Development of Cross-competencies.
• An educational setting where students or professionals, such as medical/clinical, engineering,
organization or industrial design, meet to focus on needs in the every-day realities of patients and
health care.
• Educational efforts combining professionals and/or students should be encouraged and supported.
Number of projects: 4-8 strong initiatives /
year.
Budget: Starting in 2016. Budget 1 MSEK in
2016 and ramping up to 3 MSEK in 2018 from
VINNOVA, with equal co-financing from project
partners.
Targeted groups: BME relevant educations
across Swedish universities.
5. Verification of innovations in a
clinical environment
Description:
• This funding will make it possible to set time aside for leading technology users to take part in both
the planning and the conduct of tests of new equipment in the clinic.
• Equipment intended for use in a clinical environment often needs to be tested already at the
prototype stage.
• It has become increasingly difficult for medical staff with many clinical duties to take part in
clinical trials.
• This activity will reduce the burden of adapting the environment to the test situation, and offer
support for the verification of new technology.
Number of projects: Annual calls with a
maximum of three projects granted each year.
Budget: 750,000-1.5 MSEK with an equal
amount of cofinancing from project partners.
Targeted groups: SME and research groups in
BME, medicine, economics and design.
6. Translational hub
Description:
• Set up of a national network of experienced medtech professionals (entrepreneurs, CTOs, patent
lawyers, venture capitalists) to support promising projects with useful advice and networks.
• Set up a national and area-specific angel-investor network for medtech. These activities will be
coordinated with other actors in the R&I field.
Budget: Establishment of the translational hub will
commence in 2017 with a budget of 1 MSEK/year from
VINNOVA.
Targeted groups: The academic community, institutes
and SMEs where research is conducted
7. Support for certification and
approval process
Description:
• To speed up and facilitate the certification process regarding regulatory requirements.
• Companies that provide such assistance on a commercial basis will be identified and mapped
according to expertise and offering in the product-development chain.
• The program may develop database-driven systems and templates to generate the documentation
needed for regulatory submissions.
• Offer focused courses in the field in close cooperation with existing companies.
• A consortium of individuals and companies will be formed with experience in the approval
procedure, which will provide training in the certification and approval process for newly formed
companies in the medtech field and for researchers with plans to form such companies.
Budget: A consortium will be formed. 1 MSEK per year from VINNOVA is allocated for this activity.
Targeted groups: SMEs in Sweden, Medtech Research, Innovation and Development in health care
and the academy.
8. Accelerating international
collaboration
Description:
• Creating and strengthening gateways for international
collaboration between researchers and SMEs.
• The SIP nodes may aid as hubs from which collaboration
with innovation clusters in other countries can be
developed
• Support of an advocacy platform for influencing
initiatives in the EU, including the EIT InnoLIFE KIC
granted in 2014.
• Within the imaging field, Swedish Bioimaging may serve
as a bridge to Euro-Bioimaging and its Industry Board
(http://www.eurobioimaging.eu/content-page/eurobioimaging-industry-board).
Budget: Starting in autumn 2016. Yearly budget of 1MSEK
from VINNOVA, with equal co-funding from applicant
partners.
Targeted groups: Investors, the academic community,
entrepreneurs, industry and the health care sector.
9. Health care innovator of the
year award
Description:
• An annual award for clinicians involved in procurement,
expert groups, clinical studies with a high impact on the
innovation of health-care processes enabled through new
technology.
• The award would be developed in collaboration with
Swedish Medtech and media, such as Dagens Medicin.
Budget: 0,5 MSEK / year starting 2016.
Targeted groups: Nurses, doctors and health-care staff
developing health care processes.
10. Increased awareness and
knowledge through collaboration
Description:
• The activities will include a series of events such as round-table-discussions, delegation trips,
workshops and conferences.
• Information and results from the events will be disseminated widely among the BME community.
• Purpose is to increase awareness and knowledge amongst decision makers regarding the
challenges of innovative BME and its great potential for both patients and for adapting health care.
Some initial themes might be reimbursement models for innovative, qualitative and sustainable health
care, Models for early implementation of innovative BME and procurement, and patient
empowerment.
Budget: : 0,5 MSEK / year starting 2016.
Targeted groups: Hospital staff and management, decision makers in county councils
and regions, politicians on the regional as well as the national level, the medtech industry,
governmental agencies.
Organization
•
•
•
•
Governing Board
Program office
Advisory board
20 % support from 6 noders
Swedish Medtech and SPSwedish Technical Research Inst
Advisory board
•
•
•
Industry/SME 3 st
Key Opinion Leaders
Healthcare 3 st
Patient rep/other program
(e.g. SIP) 1-3 st
Governing board
Members from counties, regions,
academy, ndustry and research
institutes
VINNOVA
Program office
Reidar Gårdebäck - ProgrDir
Project leaders
Nodes+institute
SIP Governing Board
Namn
Titel
Organisation
Magnus Lindholm
CEO
Baxter Medical AB
Tomas Mora-Morrison s
Founder
Cambio Healthcare system
Tomas Puusepp / Sören Johansson
Member of the Board
Elekta/former CEO
Elekta AB- BG
Eva Malmström/Kerstin Tham
(alternate) Dean/pro-vicechancellor
KTH Royal Institute of
Technology/Karolinska Institute - BG
Peter Värbrand
Deputy Vice-chancellor
Linköping Univ
Erik Höglund
Deputy Vice-chancellor
Luleå University of Technology
Gunilla WestergrenThorsson/Lars Dahlin
Dean/Vice-chancellor
Lund University
Anders Carlberg
R&D Director Regional
Development
Regional
Development, Region Västra Götaland
Torbjörn Kronander
CEO
Sectra AB
SIP Governing Board, continued
Namn
Titel
Organisation
Hannie Lundgren
R&D Director
Region Skåne
Maria Khorsand
CEO
SP Technical Research Institute
of Sweden
Maria Englund
Personal direktör
Stockholm County Council
Anna Lefevre Skjöldebrand
CEO
Swedish Medtech
Olle Larkö/Mats Viberg
(alternate)
Dean/Senior vice president
University of
Gothenburg/Chalmers University
of Technology - MP
Sune Larsson
Research Director Uppsala
University hospital
Uppsala county council
Anders Sylvan
Director
Västerbotten County Council
University Hospital of Umeå
Mats Palerius
CEO
Zenicor AB
Jan Marcusson
R&D director healthcare
Region Östergötland
Medical technology is a part of the
solution to meet future challenges